by admin | Sep 27, 2018 | 2018, Collaboration, Funding & Investments, Head & Neck Cancer, Milestones
We are extremely pleased to announce that 2A Pharma in collaboration with partners from The Danish Technological Institute and Danish biotech company DNA Sense have been granted EUR 653,000 Eurostars funding for 2AP07, a project to develop a therapeutic head...
by admin | Jun 25, 2018 | 2018, Funding & Investments, Milestones, Press Releases
2A Pharma is very pleased to announce that it has raised SEK 20 million (USD 2.2M) from existing and new investors. This funding augments the previously raised SEK 27 million (USD 3M) and will enable 2A Pharma to drive its leading vaccine candidate, 2AP01, a...
by admin | Dec 20, 2016 | 2016, Funding & Investments, HPV, Milestones
2A Pharma AB today closed its first financing round, raising SEK 27 million from private angel investors. This new capital will enable us to take our first project, the AAVLP-HPV vaccine, through to the end of phase I clinical studies. We are grateful for our...
Recent Comments